Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

SHOCKING: 4 - You Need To See This

Dan Ives Is Betting on Cyber-AI for 2026. 1 Stock to Load Up on Now.

Wedbush’s Dan Ives is bullish on cybersecurity firm CrowdStrike amid the AI trend.

Barchart

Dan Ives Loves This Under-the-Radar AI Stock for 2026

Wall Street likes Nebius’s AI scale story, but investors are paying upfront for growth that still needs to prove durable.

Barchart

This Dividend-Yielding Tech Stock Looks a ‘Compelling Buy’ for 2026 After 2 Years of Underperformance

Microsoft is set to underperform markets for the second consecutive year. Dan Ives of Wedbush, meanwhile, sees it as a “compelling” buy and predicts nearly 30% upside next year.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Dan Ives Is Betting That Apple and Google Will Partner in 2026. Should You Buy AAPL Stock First?

Here’s why AAPL stock probably won’t get a big lift from a potential, formal alliance with GOOG.

Barchart

Dan Ives Thinks Trump Will Invest in This Quantum Computing Stock in 2026. Should You Buy It First?

IonQ grabbed headlines on a Trump investment prediction, yet the stock’s fate still hinges on execution, not speculation.

Barchart

Will Oracle Stock Hit $250 in 2026? Dan Ives Thinks So.

Oracle is in focus as Wedbush’s Dan Ives predicts the stock could surge to $250 in 2026 on accelerating cloud and data-center momentum.

Barchart

Could 2026 Be the Year Palantir Stock Hits a $1 Trillion Valuation?

Wedbush’s Dan Ives sees Palantir reaching $1 trillion valuation in the future.

Barchart

Read news from The Economist, FT, and more,
with one subscription

The Case for Nvidia Stock Hitting $275 in 2026

After a historic run and a healthy pause, Wedbush sees AI’s next chapter setting up Nvidia and the broader tech sector for 2026.

Barchart

Analysts Are Betting Big on Rivian Stock Ahead of 2026. Should You Get In on RIVN Here Too?

Wedbush Securities sees Rivian stock pushing higher in 2026. Dan Ives explained his bullish view on RIVN shares in his recent note to clients.

Barchart

Trump Media announces $6bn merger plan with fusion power company

TMTG, which owns president’s Truth Social platform, unveils link-up TAE Technologies to respond to AI boom

The Guardian - US

Europe Is Having a ‘Gut Check’ and Dan Ives Says It’s Time to Gobble Up 2 of the Region’s Top Tech Stocks

Down over 25% from all-time highs, European tech stocks such as Klarna and Spotify are top investments, according to Dan Ives.

Barchart

A $2 Trillion Case to Buy Tesla Stock Right Now

In a new note, Wedbush reiterates its optimism on Tesla's autonomous and AI projects.

Barchart

Musk Reportedly Funding GOP Campaigns Ahead Of 2026 Midterms, Staying Away From Initiative To Create Third Party

Elon Musk is funding campaigns for Republican congressional candidates after tensions with Donald Trump thawed in the past months, according to a new report.

Latin Times

Cathie Wood Sells Over $59M of Tesla Stock Despite Wedbush Seeing a $1T AI Opportunity for the Firm

Cathie Wood sold over 124,000 Tesla shares this week across Ark Invest ETFs amid valuation concerns and a rare downgrade from Morgan Stanley.

International Business Times UK

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What's Up With The Pullback In Apple Stock Today?

Apple Inc (NASDAQ:AAPL) shares are trading marginally lower on Monday. Despite the dip, a notable analyst has raised the price target on the stock.

Benzinga

Wall Street Bull Says Apple Is Ready To Explode — 26% Rally Seen As iPhone 17 And AI Upgrade Cycle Kick In

Wedbush Securities Managing Director Dan Ives has raised his price target for Apple Inc. (NASDAQ:AAPL) to $350, projecting a potential upside of approximately 26% from current trading levels.

Benzinga

Nancy Pelosi And Dan Ives Pile Into The Same 8 AI Stocks — What Do They See Coming?

Combine one of the most well-known financial figures and the investment portfolio of the most followed member of Congress, and you will get a lot of bets on the artificial intelligence sector.

Benzinga

Snowflake Q3 AI Momentum Spikes Bookings 50%; Upside Falls Short Of Q2

Shares of Snowflake Inc. (NYSE:SNOW) tanked in early trading on Thursday, even after the company reported upbeat third-quarter results on Wednesday.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Why C3.ai Q2 Revenue Beat Impresses Analysts

C3.ai Inc (NYSE:AI) shares rose in early trading on Thursday, after the company on Wednesday reported upbeat fiscal second-quarter results.

Benzinga

Salesforce's Q3 Wins Broad Analyst Praise As AI Momentum Builds

Shares of Salesforce Inc. (NYSE:CRM) rose in early trading on Thursday, after the company reported upbeat third-quarter results on Wednesday.

Benzinga

CrowdStrike Stock Slides Despite Upbeat Q3, Falcon's Wingspan Widens

Shares of CrowdStrike Holdings Inc (NASDAQ:CRWD) tanked in early trading on Wednesday, despite the company reporting upbeat fiscal third-quarter results.

MarketBeat

Palantir Stock Finds Its Footing—and a Path to Global Growth

Palantir stock is down 14% in a month, but new international wins and AI momentum suggest PLTR may be setting up for a bullish rebound

Barchart

Dan Ives Says AI Bubble Fears Are ‘Overblown’ and He’s Betting on This 1 Data Center Stock Now

Ives just added IREN to his list of the top 30 AI winners.

Benzinga

Dan Ives-Inspired AI ETF Took A November Beating — Is There More Pain Ahead?

The Dan IVES Wedbush AI Revolution ETF (NYSE:IVES), a fund specifically designed to capture the rapid growth of artificial intelligence, saw its powerful initial momentum stall in November, posting a 7.51% decline for the month.

Benzinga

MongoDB Stock Soars, 9 Analysts Hike Estimates After Blockbuster Results

MongoDB Inc (NASDAQ:MDB) shares climbed in early trading on Tuesday after the company reported upbeat fiscal third-quarter results.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations